David R. Tawil joined Milberg as Senior Counsel in 2026, where he focuses his practice on mass arbitration, representing thousands of consumers. He brings over a decade of experience as part of the plaintiffs’ mass tort bar, including key roles in high-profile complex litigation at both the trial and appellate levels. David has been consistently recognized as a “Rising Star” by Super Lawyers and selected for Best Lawyers’ “Ones to Watch” in Plaintiffs’ Product Liability Litigation and Mass Tort/Class Actions.

Prior to joining Milberg, David was a key member of several significant trial teams, including a Testosterone Replacement Therapy team that was selected as a finalist for the 2017 “Trial Team of the Year” by National Trial Lawyers. He likewise contributed to all aspects of discovery in the 3M Combat Arms Earplug litigation, the national Opioids litigation, and several class actions related to the diesel emissions scandal perpetrated by companies including Volkswagen, Bosch, and Mercedes-Benz. Additionally, David spearheaded briefing that led to several groundbreaking decisions by the New Jersey Appellate Division and Supreme Court in the Accutane litigation.

David earned his law degree from Tulane Law School, where he served as Associate Justice of the Tulane Moot Court Board, competed on the mock trial team, and was the Senior Notes and Comments Editor of the Tulane Journal of International and Comparative Law, which published his case note on the Alien Tort Statute. Following law school, he returned to New Jersey to serve as a Multicounty Litigation and Civil Division law clerk to the Honorable Jessica R. Mayer—now a Presiding Judge of the Appellate Division—assisting on a mass tort bellwether trial involving the drug Zometa.

Outside the office, David captains and plays quarterback for a competitive travel flag football team, hangs out with his husky, Jay, and closely follows the Knicks and Saints.